19 May 2013
Keywords: fda, clears, app, polmyxin, sulfate, specialty, drug
Article | 21 January 2008
US specialty drug developer APP Pharmaceuticals has received Food and Drug Administration approval for its Polmyxin B Sulfate injection
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 January 2008
17 May 2013
© 2013 thepharmaletter.com